Salman Abdulaziz MBBS, FRCP , Vivek Kakar MD, FRCA , Huda Alfoudri MBChB, FCARCSI , Mohammed Shalaby MD , Mikaela V. Allen NMD , Shameena Beegom RN, MSc , John F. Fraser MBChB, PhD, FRCP, FRCA, FFARCSI, FCICM, FELSO , Saleh Fares Al Ali MD, MPH
{"title":"Circulatory Extracorporeal Membrane Oxygenation Support for High-Risk Acute Pulmonary Embolism","authors":"Salman Abdulaziz MBBS, FRCP , Vivek Kakar MD, FRCA , Huda Alfoudri MBChB, FCARCSI , Mohammed Shalaby MD , Mikaela V. Allen NMD , Shameena Beegom RN, MSc , John F. Fraser MBChB, PhD, FRCP, FRCA, FFARCSI, FCICM, FELSO , Saleh Fares Al Ali MD, MPH","doi":"10.1016/j.chstcc.2024.100096","DOIUrl":null,"url":null,"abstract":"<div><div>High-risk pulmonary embolism (PE), defined as obstruction of the pulmonary arterial tree that leads to hemodynamic instability, is a common cause of cardiac arrest, with a mortality rate of up to 50%. The obstruction of the pulmonary circulation interferes with gas exchange and causes hemodynamic disturbances in both the right and left sides of the heart. Some international guidelines have suggested the use of extracorporeal membrane oxygenation (ECMO), in combination with definitive therapy, in patients with PE with refractory circulatory collapse or cardiac arrest. Furthermore, several observational studies have shown that ECMO may be beneficial in stabilizing patients with high-risk PE, especially as a form of bridging therapy in patients for whom common reperfusion methods may be insufficient or have delayed efficacy. We present the case of a patient with acute high-risk PE and the role of ECMO in addressing the physiologic derangements caused by PE and improving patient outcomes. We reviewed the literature reporting the experience on ECMO use in conjunction with various forms of definitive treatment for PE. We describe the various ECMO cannulation strategies applicable for patients with high-risk PE, the role of adjunct mechanical circulatory support, practical guidance on ECMO weaning, and the interaction between the PE response team and the ECMO team in the setting of high-risk PE.</div></div>","PeriodicalId":93934,"journal":{"name":"CHEST critical care","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CHEST critical care","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949788424000509","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
High-risk pulmonary embolism (PE), defined as obstruction of the pulmonary arterial tree that leads to hemodynamic instability, is a common cause of cardiac arrest, with a mortality rate of up to 50%. The obstruction of the pulmonary circulation interferes with gas exchange and causes hemodynamic disturbances in both the right and left sides of the heart. Some international guidelines have suggested the use of extracorporeal membrane oxygenation (ECMO), in combination with definitive therapy, in patients with PE with refractory circulatory collapse or cardiac arrest. Furthermore, several observational studies have shown that ECMO may be beneficial in stabilizing patients with high-risk PE, especially as a form of bridging therapy in patients for whom common reperfusion methods may be insufficient or have delayed efficacy. We present the case of a patient with acute high-risk PE and the role of ECMO in addressing the physiologic derangements caused by PE and improving patient outcomes. We reviewed the literature reporting the experience on ECMO use in conjunction with various forms of definitive treatment for PE. We describe the various ECMO cannulation strategies applicable for patients with high-risk PE, the role of adjunct mechanical circulatory support, practical guidance on ECMO weaning, and the interaction between the PE response team and the ECMO team in the setting of high-risk PE.
高危肺栓塞(PE)是指导致血液动力学不稳定的肺动脉树阻塞,是心脏骤停的常见原因,死亡率高达 50%。肺循环受阻会影响气体交换,导致心脏左右两侧血流动力学紊乱。一些国际指南建议,对于出现难治性循环衰竭或心跳骤停的 PE 患者,可使用体外膜肺氧合(ECMO),并结合确定性疗法。此外,一些观察性研究表明,ECMO 有助于稳定高危 PE 患者的病情,尤其是作为一种桥接疗法,用于普通再灌注方法可能不足或疗效延迟的患者。我们介绍了一名急性高危 PE 患者的病例,以及 ECMO 在解决 PE 引起的生理失调和改善患者预后方面的作用。我们回顾了有关 ECMO 与各种形式的 PE 最终治疗结合使用的文献。我们介绍了适用于高危 PE 患者的各种 ECMO 插管策略、辅助机械循环支持的作用、ECMO 断流的实用指南以及 PE 反应团队与 ECMO 团队在高危 PE 情况下的互动。